Clinical Trial Update: BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating BT062 in combination with lenalidomide or pomalidomide and dexamethasone in patients with multiple myeloma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BT062

Snippet

Sponsor: Biotest Pharmaceuticals Corporation | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED